Specifically, we sought to determine whether oligomers and fibrils of Aβ42, the putative pathogenic agent in AD, could elevate endogenous APP, BACE1, and β-secretase cleavage of APP in astrocytes. The gene discussed is APP; the disease is Alzheimer disease.